SKI Market

A+| A| A-|

Indian Indices

Sensex

77,664.00 -852.49
( -1.09%)

Global Indices

Nasdaq

49,509.71 339.32
(0.69%)

Dow Jones

7,158.76 73.75
(1.04%)

Hang Seng

59,249.10 -336.76
(-0.57%)

Nikkei 225

10,468.22 -8.24
(-0.08%)

Forex

USD-INR

93.44 0.45
(0.48%)

EUR-INR

109.88 0.43
(0.39%)

GBP-INR

126.24 0.55
(0.44%)

JPY-INR

0.59 0.00
(0.27%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

330.3875196

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

36.79

34689.63

EPS(TTM)

Face Value()

Div & Yield %

75.48

1.01

Back

Ajanta Pharma's Paithan unit concludes USFDA inspection

Apr 22,2026

Ajanta Pharma announced that the USFDA has concluded an inspection at its manufacturing facility at Paithan, in Maharashtra. The Inspection was conducted from 13 April 2026, to 21 April 2026, and closed with the issuance of Form-483 with 5 (five) observations.

77,664.00 -852.49 ( -1.09%)

49,509.71 339.32 (0.69%)

7,158.76 73.75 (1.04%)

59,249.10 -336.76 (-0.57%)

10,468.22 -8.24 (-0.08%)

93.44 0.45 (0.48%)

109.88 0.43 (0.39%)

126.24 0.55 (0.44%)

0.59 0.00 (0.27%)